{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:16:44Z","timestamp":1788347804753,"version":"build-2803163510"},"reference-count":38,"publisher":"Bioscientifica","issue":"9","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The SDHC c.397C&amp;gt;T (p.Arg133Ter) germline pathogenic variant is present in over 40% of mutation-positive paragangliomas in French-Canadian patients, supporting a founder effect. We aimed to characterize pheochromocytomas and paragangliomas (PPGLs) associated with this variant in a large international cohort of European descent. We conducted an international case series of adults with PPGLs carrying the SDHC c.397C&amp;gt;T germline pathogenic variant, treated between 2010 and 2024 at four university hospitals: two in the province of Qu\u00e9bec (Canada), one in the Northeastern United States, and one in France. Among the 45 patients confirmed with PPGLs harboring the SDHC c.397C&amp;gt;T pathogenic variant, 46.7% were women, and the mean age at diagnosis was 49.7 years. Forty-four patients (97.8%) had paragangliomas, and one (2.2%) had a pheochromocytoma. The most common paraganglioma sites were the head and neck (26\/44, 59.1%), followed by the thoracic (including mediastinal) region (12\/44, 27.3%; half located in or near cardiac structures), and finally the abdominal region (6\/44, 13.6%). Multiple tumors were present in 15.6% (7\/45) of cases, and metastatic disease was identified in 11.1% (5\/45). Following surgical resection, four patients (15.4%) experienced recurrence during a mean follow-up of 7.9 years. Loss of SDHB protein expression was confirmed in all available immunohistochemistry samples. The SDHC c.397C&amp;gt;T founder pathogenic variant, likely originating from France, is common in the province of Qu\u00e9bec, with probable migration to New England (USA), and appears enriched for thoracic (including mediastinal) paragangliomas. Although based on a limited series, affected patients remain at risk of recurrence and metastasis and should be followed up closely.<\/jats:p>","DOI":"10.1530\/erc-26-0296","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:12:35Z","timestamp":1786363955000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["<i>SDHC c.397C&amp;gt;T-<\/i>\n                    related pheochromocytomas and paragangliomas: insights from an international study"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-4181","authenticated-orcid":true,"given":"S","family":"Parisien-La Salle","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) Research Center (CRCHUM) 1 , , ,","place":["Montreal, Quebec, Canada"]},{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Metabolism, Mass General Brigham, Harvard Medical School 2 , , ,","place":["Boston, Massachusetts, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Perreault","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) Research Center (CRCHUM) 1 , , ,","place":["Montreal, Quebec, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mahrokhian","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Metabolism, Mass General Brigham, Harvard Medical School 2 , , ,","place":["Boston, Massachusetts, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Dumas","sequence":"additional","affiliation":[{"name":"Division of Genetics, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al Research Center (CRCHUM) 3 , , ,","place":["Montreal, Quebec, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Corbeil","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) Research Center (CRCHUM) 1 , , ,","place":["Montreal, Quebec, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-3025","authenticated-orcid":true,"given":"A","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) Research Center (CRCHUM) 1 , , ,","place":["Montreal, Quebec, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine G\u00e9nomique des Tumeurs et des Cancers, F\u00e9d\u00e9ration de G\u00e9n\u00e9tique et de M\u00e9decine G\u00e9nomique, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Europ\u00e9en Georges Pompidou 4 , ,","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Metabolism, Mass General Brigham, Harvard Medical School 2 , , ,","place":["Boston, Massachusetts, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"St-Jean","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Sherbrooke 5 , , ,","place":["Sherbrooke, Quebec, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Bourdeau","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) Research Center (CRCHUM) 1 , , ,","place":["Montreal, Quebec, Canada"]},{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Metabolism, Mass General Brigham, Harvard Medical School 2 , , ,","place":["Boston, Massachusetts, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2026090206514065100_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2021","journal-title":"Endocr Rev"},{"key":"2026090206514065100_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2024.101939","article-title":"Recent progress in molecular classification of phaeochromocytoma and paraganglioma","volume":"38","author":"Boehm","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026090206514065100_bib3","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0373","article-title":"Update on the genetics of paragangliomas","volume":"30","author":"Gimenez-Roqueplo","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"2026090206514065100_bib4","first-page":"72","article-title":"The emerging role of succinate dehydrogenase genes (SDHx) in tumorigenesis","volume":"13","author":"Nazar","year":"2019","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"2026090206514065100_bib5","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1158\/1078-0432.CCR-16-0606","article-title":"Pheochromocytoma: the first metabolic endocrine cancer","volume":"22","author":"Jochmanova","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2026090206514065100_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"2026090206514065100_bib7","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1210\/jc.2016-1665","article-title":"A SDHC founder mutation causes paragangliomas (PGLs) in the French Canadians: new insights on the SDHC-related PGL","volume":"101","author":"Bourdeau","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090206514065100_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/cen.14618","article-title":"Genetic spectrum in a Canadian cohort of apparently sporadic pheochromocytomas and paragangliomas: new data on multigene panel retesting over time","volume":"96","author":"Parisien-La Salle","year":"2021","journal-title":"Clin Endocrinol"},{"key":"2026090206514065100_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1399-0004.2005.00497.x","article-title":"Population history and its impact on medical genetics in Qu\u00e9bec","volume":"68","author":"Laberge","year":"2005","journal-title":"Clin Genet"},{"key":"2026090206514065100_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cjco.2020.01.003","article-title":"Familial hypercholesterolemia and the founder effect among Franco-Americans: a brief history and call to action","volume":"2","author":"Mszar","year":"2020","journal-title":"CJC Open"},{"key":"2026090206514065100_bib11","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","article-title":"Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas","volume":"23","author":"Garcia-Carbonero","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"2026090206514065100_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004756","article-title":"First case report of an adrenocortical carcinoma caused by a BRCA2 mutation","volume":"95","author":"El Ghorayeb","year":"2016","journal-title":"Medicine"},{"key":"2026090206514065100_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/ERC-15-0099","article-title":"Structural and functional consequences of succinate dehydrogenase subunit B mutations","volume":"22","author":"Kim","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"2026090206514065100_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/15353702221147567","article-title":"Succinate dehydrogenase complex subunit C: role in cellular physiology and disease","volume":"248","author":"Wang","year":"2023","journal-title":"Exp Biol Med"},{"key":"2026090206514065100_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.freeradbiomed.2023.07.023","article-title":"Assembly of mitochondrial succinate dehydrogenase in human health and disease","volume":"207","author":"Cao","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"2026090206514065100_bib16","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1210\/clinem\/dgae797","article-title":"Biomarkers improving genetic and metastatic disease prediction in paraganglioma: insights from a prospective study","volume":"110","author":"Drossart","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090206514065100_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a multinational study of the European Network for the study of adrenal tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod Pathol"},{"key":"2026090206514065100_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.21873\/anticanres.11381","article-title":"Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation","volume":"37","author":"Santi","year":"2017","journal-title":"Anticancer Res"},{"key":"2026090206514065100_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmedgenet-2018-105427","article-title":"Bayesian approach to determining penetrance of pathogenic SDH variants","volume":"55","author":"Benn","year":"2018","journal-title":"J Med Genet"},{"key":"2026090206514065100_bib20","first-page":"870","article-title":"Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England","volume":"56","author":"Triggs-Raine","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2026090206514065100_bib21","doi-asserted-by":"crossref","first-page":"E1482","DOI":"10.1210\/jc.2013-3853","article-title":"The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3)","volume":"99","author":"Else","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090206514065100_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.14594","article-title":"SDHC phaeochromocytoma and paraganglioma: a UK-wide case series","volume":"96","author":"Williams","year":"2022","journal-title":"Clin Endocrinol"},{"key":"2026090206514065100_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107296","article-title":"Mediastinal paraganglioma: a retrospective analysis of 51 cases","volume":"216","author":"Kanj","year":"2023","journal-title":"Respir Med"},{"key":"2026090206514065100_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2350-10-34","article-title":"The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients","volume":"10","author":"Bayley","year":"2009","journal-title":"BMC Med Genet"},{"key":"2026090206514065100_bib25","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/jc.2008-2756","article-title":"Genetics of pheochromocytoma and paraganglioma in Spanish patients","volume":"94","author":"Casc\u00f3n","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090206514065100_bib26","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/clinem\/dgad028","article-title":"Evidence for a founder effect of SDHB exon 1 deletion in Brazilian patients with paraganglioma","volume":"108","author":"Fagundes","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090206514065100_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2024.101922","article-title":"Personalized management for phaeochromocytomas and paragangliomas in Latin America: a genetic perspective","volume":"39","author":"Freitas-Castro","year":"2025","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026090206514065100_bib28","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41431-018-0116-4","article-title":"Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers","volume":"26","author":"Heesterman","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"2026090206514065100_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/jhg.2009.142","article-title":"Identification of a 4.9-kilo base-pair alu-mediated founder SDHD deletion in two extended paraganglioma families from Austria","volume":"55","author":"Janecke","year":"2010","journal-title":"J Hum Genet"},{"key":"2026090206514065100_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.999329","article-title":"SDHB exon 1 deletion: a recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas","volume":"13","author":"Manotas","year":"2023","journal-title":"Front Genet"},{"key":"2026090206514065100_bib31","doi-asserted-by":"crossref","first-page":"L23","DOI":"10.1530\/ERC-12-0399","article-title":"A founder SDHB mutation in Portuguese paraganglioma patients","volume":"20","author":"Martins","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"2026090206514065100_bib32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/gcc.1144","article-title":"Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene","volume":"31","author":"Taschner","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"2026090206514065100_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","article-title":"SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma","volume":"11","author":"Bayley","year":"2010","journal-title":"Lancet Oncol"},{"key":"2026090206514065100_bib34","doi-asserted-by":"crossref","first-page":"e3635","DOI":"10.1210\/clinem\/dgaf149","article-title":"New insights into the clinical characterization of SDHAF2-related familial paraganglioma syndrome","volume":"110","author":"Fernandez-Pombo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090206514065100_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ohn.274","article-title":"Reduced risk of corporal tumors in patients with head and neck paragangliomas with p.Pro81Leu mutations","volume":"169","author":"Miller","year":"2023","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2026090206514065100_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","article-title":"Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","journal-title":"J Med Genet"},{"key":"2026090206514065100_bib37","doi-asserted-by":"crossref","first-page":"E2009","DOI":"10.1210\/jc.2011-1244","article-title":"Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect","volume":"96","author":"Yeap","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090206514065100_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12881-014-0111-8","article-title":"Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations","volume":"15","author":"Bayley","year":"2014","journal-title":"BMC Med Genet"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0296\/523384\/erc-26-0296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0296\/523384\/erc-26-0296.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:52:00Z","timestamp":1788346320000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/9\/e260296\/77976\/SDHC-c-397C-gt-T-related-pheochromocytomas-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-26-0296","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"e260296"}}